The Harvard Medical School Cancer Biology and Therapeutics Program (HMS-CBT) is a joint initiative of the Harvard Medical School Office of Global Education and the Qatar Biomedical Research Institute (QBRI). HMS-CBT is a 12-month blended-learning program (hms.harvard.edu/cbt) designed to provide participants with deep knowledge of the cancer biology that shapes modern preventive and therapeutic approaches.
Key Features:
The course structure will be comprised of:
Who Should Apply?
Candidates holding an MD, PhD, MBBS, DMD, DDS, PharmD, DNP, or equivalent degree are eligible to apply. Candidates with a Master's degree will be considered for admission on a case-by-case basis.
Scholarships
QBRI will offer a limited number of full and partial scholarships to qualified participants from the Gulf Cooperation Council (GCC) and Middle East North Africa (MENA). These Scholarships are awarded on the basis of merit and conditions stipulated by the sponsor.
For more information visit hms.harvard.edu/cbt
email to cbt@hms.harvard.edu or qbri-info@qf.org.qa